clinical use
Last reviewed 01/2018
- like other class I anti-arrhythmic drugs, the use of flecainide is usually limited to patients with structurally normal hearts
- the main use is the termination of symptomatic acute atrial fibrillation and in the prevention of recurrence of atrial fibrillation